Yi-zhong Zhang
Dr. Neher's Biophysics Laboratory For Innovative Drug Discovery, State Key Laboratory Of Quality Research In Chinese Medicine, Avenida Wai Long
Macao, China
Macao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody.
Journal: Frontiers in pharmacology
Published: March 15, 2025
Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 12, 2023
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.
Journal: Pharmacological research
Published: January 02, 2023
Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response.
Journal: Pharmacological research
Published: February 26, 2022
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.
Journal: Cancer letters
Published: March 22, 2021
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling.
Journal: Pharmacological research
Published: February 18, 2021
Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: December 27, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026